Pfizer, Rowan pursue solvent recovery

Pfizer (NYSE:PFE) has teamed with Rowan University to develop green manufacturing techniques. The focus is solvents--often the primary waste component in API production.

The collaborators are investigating the economic and environmental impacts of solvent recovery and reuse in small-volume waste streams, as opposed to incineration. Solvent recovery is already used in large-scale operations, but existing techniques don't lend themselves to small-scale operations.

The Rowan team designed a system for isopropanol solvent recovery from the manufacture of nelfinavir, the active ingredient in the antiretroviral drug Viracept. Researchers also evaluated the system for use with other of Pfizer's small-volume waste streams from multi-product facilities.

Computer-based life-cycle assessment for three drugs showed CO2 emission reductions of 677,000 kg per year.

- read the article

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.